Navigation Links
QLT announces first quarter results for 2009
Date:4/28/2009

be available via the Internet and also via telephone at 1-800-319-6413 (North America) or 604-638-9010 (International), access code 7157, followed by the "number" sign.

About QLT

QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the field of ophthalmology. In addition, we utilize three unique technology platforms, photodynamic therapy, Atrigel(R) and punctal plugs with drugs, to create products such as Visudyne(R) and Eligard(R) and future product opportunities. For more information, visit our web site at www.qltinc.com.

    QLT Inc. - Financial Highlights
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    -----------------------------------------------
                                                          Three months ended
                                                              March 31,
    (In thousands of United States dollars,
     except per share information)                        2009          2008
    -------------------------------------------------------------------------
    (Unaudited)
    Revenues
      Net product revenue                           $   20,817    $   20,016
      Royalties                                          8,907         6,301
      Licensing, milestones and other                      367           377
    -------------------------------------------------------------------------
                                                    $   30,091    $   26,694
    -------------------------------------------------------------------------

    Costs and expenses
      Cost of sales(1)                                  12,998        11,757
      Research and development                           5,886         8,048
      Selling, general and
'/>"/>
SOURCE QLT Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Copper Conferencing Announces Dr. Joy Ohayia Kicks Off the Women In Business Track of The Business Webinar Series - A Free Online Learning Series for Business Professionals
2. The Quantum Group Announces Filing of Utility Patent Application
3. LCA-Vision Announces First Quarter 2009 Financial Results
4. BD Announces Results for Second Fiscal Quarter
5. CPC Announces Conference Call of Annual Meeting of Stockholders
6. Product Stewardship Institute Announces Two New Sustaining Partners
7. Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009
8. Pennsylvania Dental Association Announces Winners of Annual Statewide Third-Grade Student Poster Contest
9. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
10. STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call
11. Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...eveloped by Opticom Data Research, FloatScope is a...of the eye. , New Westmin...s a new hand-held device for self-examination of t... health conditions such as floaters and opacities ...ing of the iris., , , FloatScope uses a beam of l...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...edicalGenetics(ACMG)EncouragesFamiliestoGatherFami...ay,Thanksgiving2009 ,, BETHESDA,Md.,Nov.23/PRN...ualNationalFamilyHistoryDay,asdeclaredbytheU.S.Sur...MG)encourageseveryonetoknowtheirfamilymedicalhisto...fe-savinginformation,to"starttheconversation"about...
(Date:11/23/2009)...RNewswire-USNewswire/--TheAmericanSocietyofHematol...g,education,andmediacompany,arelaunching"Exploreth...tosparkinterestinthefieldsofscienceandmedicine,ina...tiesinhematology. ,, "Manyhematologistsmayremem...icent,whichmadelearningaboutbloodreallyfun,"stated...
(Date:11/23/2009)...-- A first-of-its-kind consensus statement on diab...als of Surgery . The report illustrates the findin... -- Diabetes Surgery Summit (DSS) -- where an inte...ical experts agreed on a set of evidence-based gui...e use and study of gastrointestinal surgery to tre...
Breaking Medicine News(10 mins):Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2Health News:'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5
... last 25 years, in New York, there has been a decl...although its frequency has increased. Researchers ...malignant melanoma, the deadliest form of skin can...100,000. For women, the corresponding increase was...
...chers at the University of Texas, offer some valua...ke is enough.Vitamin D is essential for healthy bo...any bone related disease. Doctors believe that nat...actors can reduce sunlight exposure, such as windo...
...chers at the critical care centre felt that, every...fe-threatening response to infection. Sepsis occur...ten follows trauma, surgery or is associated with ...ng cause of death in intensive care. Dr Jean...
...ing to researchers, after analysis of cells in men...proof is the piling up that the heart may be able ...g cells from elsewhere in the body.// Traditionall...h is found only in men, researchers determined tha...
...nt study shows that many people with firm spiritua...t. Researchers in Texas have studied 120 relatives...erminal care. They looked at how the presence,// o...dy progress in coming to terms with their loss ove...
...ing to a new research, oxygen therapy at home redu...searchers at the University Hospital of Denmark, h...with smoker's lungs// - where the blood becomes de..., proved to be beneficial. The patients had a 40 p...
Other Medicine News:
(Date:11/23/2009)...ss.,Nov.23/PRNewswire-FirstCall/--BostonScientific...hePiperJaffrayHealthCareConference,December1-2. ,...dSamLeno,ExecutiveVicePresidentandChiefFinancialOf...eCompanyonTuesday,December1st,beginningatapproxima...nwillbeavailabletoallinterestedpartiesatBostonScie...
(Date:11/23/2009)...MOND,Calif.,Nov.23/PRNewswire-FirstCall/--Transcep...thatitisscheduledtomeetwiththeU.S.FoodandDrugAdmin...ResponseLetterregardingtheNewDrugApplication(NDA)f...ablet).Aspreviouslyannounced,theCompleteResponseLe...thattheFDAcouldnotapprovetheNDAinitspresentform.Th...
(Date:11/23/2009)...AKS,Calif.,Nov.23/PRNewswire-FirstCall/--Amgen(Nas...gforBestOverallPipelineandforBestNewDrugforNplate&..., TheBestOverallPipelineawardwaspresentedtoAmgenby...etpotentialofthecompany,spipeline,aswellasitsmixof...dges,Amgen,spipelineisnotableforitsfocusonunmetcli...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Join WQED Pittsburgh and The Press Club of Western Pennsylvania in Celebrating National Healthy Aging 28R 29 Month and Kick Off Active Aging Week Sept 55906 1Sen Durbin Congressmen Get Health Care Reform Message in a Bottle from AARP 55904 1Sen Durbin Congressmen Get Health Care Reform Message in a Bottle from AARP 55904 2Biotech Cools Off in August But Capital Markets Remain Positive 13779 1Biotech Cools Off in August But Capital Markets Remain Positive 13779 2Biotech Cools Off in August But Capital Markets Remain Positive 13779 3Biotech Cools Off in August But Capital Markets Remain Positive 13779 4
... Percent Fewer RA Patients,Reported Job Loss When ...o Methotrexate Alone, BARCELONA, Spain, June 15, 2... (RA) is one of the most common causes of,disabili...how that,rheumatoid arthritis (RA) patients treate...ing longer, had fewer absences and reported,greate...
...n 18, 2007 - Novelos,Therapeutics, Inc. (OTCBB: NV...velopment of therapeutics to treat cancer and,hepa...ngoing,Dana-Farber/Partners Cancer Care (DF/PCC) P...latin in platinum-resistant ovarian,cancer patient...erall tumor response (assessed at least after 8 we...
Other Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 2Novelos Therapeutics Announces Encouraging Results in Ongoing Phase,2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care 3
MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
Ascent Anterior Referencing Femoral Instrument Case
Ascent Knee System Case # 2
Lineage Acetabular Cup System (Ceramic)
Medicine Products: